Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease - 30/05/13
Doi : 10.1016/j.jaci.2013.01.045
Carline E. Tacke, MD a 
, Gaby P. Smits, MSc b, Fiona R.M. van der Klis, PhD b, Irene M. Kuipers, MD, PhD c, Hans L. Zaaijer, MD, PhD d, Taco W. Kuijpers, MD, PhD a
, Gaby P. Smits, MSc b, Fiona R.M. van der Klis, PhD b, Irene M. Kuipers, MD, PhD c, Hans L. Zaaijer, MD, PhD d, Taco W. Kuijpers, MD, PhD a a Department of Pediatric Hematology, Immunology and Infectious Diseases, Academic Medical Center, Amsterdam, The Netherlands
b Center for Infectious Disease Control Netherlands, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
c Department of Pediatric Cardiology, Academic Medical Center, Amsterdam, The Netherlands
d Department of Clinical Virology, Academic Medical Center, Amsterdam, The Netherlands
| This work was supported by the Stinafo foundation (grant no. 2008051, The Hague, The Netherlands). |
|
| Disclosure of potential conflict of interest: C. Tacke has received a grant from the Stinafo Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 6
P. 1701-1703 - juin 2013 Retour au numéro
Article précédent
- Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement
- Shradha Agarwal, Charlotte Cunningham-Rundles
- Approved and unapproved use of immunoglobulins in Iceland
- Bryndís Ester Ólafsdóttir, Davíð Þór Þorsteinsson, Rannveig Einarsdóttir, Björn Rúnar Lúðvíksson, Gerður Gröndal, Kristján Erlendsson, Ásgeir Haraldsson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?